David Hunkar submits:
In a recent article, I wrote that U.S. public healthcare spending is projected to exceed private spending by 2012. U.S. healthcare expenditures was estimated to reach about 17.3% of the GDP in 2009. One of the beneficiaries of all this spending are the companies in the healthcare industry such as drug makers, health insurers, etc. They may all perform well in the coming years as a result.
The table below lists the major drug stocks trading on the NYSE: